These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3582190)

  • 1. [Duodenal ulcer and antibiotic therapy].
    Hirschl AM; Stanek G; Rotter M; Hentschel E; Schütze K
    Dtsch Med Wochenschr; 1987 May; 112(19):781. PubMed ID: 3582190
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with the treatment of duodenal ulcer associated with Campylobacter pylori infection by combined use of anti-secretory and antibacterial drugs].
    Grigo'rev PIa; Isakov VA; Iakovenko EP; Agrba VZ; Stepanov AV; Shcherbatykh SI
    Klin Med (Mosk); 1989 Aug; 67(8):52-5. PubMed ID: 2681993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined drug therapy against Campylobacter in duodenal ulcer and non-ulcerous dyspepsia].
    Tyszkiewicz T
    Lakartidningen; 1989 Mar; 86(10):843. PubMed ID: 2921896
    [No Abstract]   [Full Text] [Related]  

  • 4. Campylobacter pyloridis is not responsible for duodenal ulcer formation, result of a controlled therapeutic trial.
    Kumar N; Punjabi ND; Jain PC; Srivastava S
    J Assoc Physicians India; 1988 Sep; 36(9):574-5. PubMed ID: 3074085
    [No Abstract]   [Full Text] [Related]  

  • 5. Bismuth, Campylobacter, and ulcer relapse.
    de Wal J
    Lancet; 1988 Apr; 1(8589):824. PubMed ID: 2895340
    [No Abstract]   [Full Text] [Related]  

  • 6. Omeprazole, campylobacter pylori, and duodenal ulcer.
    Mainguet P; Delmée M; Debongnie JC
    Lancet; 1989 Aug; 2(8659):389-90. PubMed ID: 2569579
    [No Abstract]   [Full Text] [Related]  

  • 7. [Campylobacter pylori and gastroduodenal pathology].
    Ramírez Ramos A; León Barúa R; Gilman R; Recavarren Arce S; Spira W; Watanabe Yamamoto J; Garrido Klinge G; Rodríguez Ulloa C; Bonilla JJ; Cok García J
    G E N; 1987; 41(3):116-9. PubMed ID: 3149940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanisms of the origin of duodenal ulcer].
    Ryss ES; Fishzon-Ryss IuI
    Klin Med (Mosk); 1990 Mar; 68(3):17-21. PubMed ID: 2370751
    [No Abstract]   [Full Text] [Related]  

  • 9. Bismuth/ofloxacin combination for duodenal ulcer.
    Bayerdörffer E; Simon T; Bästlein C; Ottenjann R; Kasper G
    Lancet; 1987 Dec; 2(8573):1467-8. PubMed ID: 2892030
    [No Abstract]   [Full Text] [Related]  

  • 10. Ciprofloxacin resistance among human Campylobacter isolates 1991-2004: an update.
    Dingle KE; Clarke L; Bowler IC
    J Antimicrob Chemother; 2005 Aug; 56(2):435-7. PubMed ID: 15956098
    [No Abstract]   [Full Text] [Related]  

  • 11. Colloidal bismuth subcitrate (DE-NOL) and tinidazole healed duodenal ulceration with a low relapse rate due to elimination of Campylobacter pylori.
    Goodwin CS; Marshall BJ; Blackbourn SJ; Warren JR; Phillips M
    J Chemother; 1989 Jul; 1(4 Suppl):838-9. PubMed ID: 16312662
    [No Abstract]   [Full Text] [Related]  

  • 12. Campylobacter pylori and development of duodenal ulcer.
    Wyatt JI; Rathbone BJ; Dixon MF; Heatley RV; Axon AT
    Lancet; 1988 Jan; 1(8577):118-9. PubMed ID: 2891957
    [No Abstract]   [Full Text] [Related]  

  • 13. Ciprofloxacin resistance does not affect duration of domestically acquired campylobacteriosis.
    Cox LA; Copeland D; Vaughn M
    J Infect Dis; 2005 May; 191(9):1565-6; author reply 1566-7. PubMed ID: 15809917
    [No Abstract]   [Full Text] [Related]  

  • 14. Ciprofloxacin-resistant Campylobacter.
    Menzies F; McDowell S; Neill S
    Vet Rec; 2003 Jan; 152(3):91; author reply 91. PubMed ID: 12570315
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spondylodiscitis and an aortic aneurysm due to Campylobacter coli.
    Lemaire X; Dehecq C; Cattoen C; Garnier LD; Bournet BS; Yazdanpanah Y; Senneville E
    Ann Clin Microbiol Antimicrob; 2010 Feb; 9():8. PubMed ID: 20132561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Should H. pylori infection in duodenal ulcer be confirmed before administering eradicating treatment?].
    Gisbert JP; Pajares JM
    Med Clin (Barc); 1999 Jul; 113(4):134-7. PubMed ID: 10472599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacotherapy of stomach and duodenal ulcers].
    Grigor'ev PIa; Iakovenko EP
    Sov Med; 1986; (9):58-64. PubMed ID: 3798225
    [No Abstract]   [Full Text] [Related]  

  • 19. [H. pylori and chronic duodenal ulcer: eradication therapy with ranitidine-antibiotic combination and follow-up of ulcer disease].
    Holtmann G; Layer P
    Z Gastroenterol; 1994 Aug; 32(8):474-5. PubMed ID: 7975793
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of helicobacteriosis in stomach and duodenal lesions].
    Ostrovskiĭ IM
    Ter Arkh; 1998; 70(2):73-6. PubMed ID: 9551581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.